Healthy Skepticism Library item: 3389

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Rothschild M.
Death by prescription
The Progressive 1986; 50:(6):18, 20-22

Abstract:

(Limited to parts of article dealing with promotion.) Before and after Pfizer launched its nonsteroidal anti-inflammatory drug Feldene (piroxicam) its promotion for the product has run afoul of the Food and Drug Administration. Pfizer has also tried to intervene to stop publication of medical studies critical of its product.

Keywords:
*feature story/United States/Pfizer/Feldene/piroxicam/Food and Drug Administration/FDA/NSAID/ nonsteroidal anti-inflammatory drugs/ editorial freedom/EVALUATION OF PROMOTION: JOURNAL ADVERTISEMENTS/INFLUENCE OF PROMOTION: PUBLICATION